ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 66 filers reported holding ONCOMED PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $24,000 | -78.2% | 10,429 | -61.4% | 0.00% | -80.0% |
| Q4 2017 | $110,000 | -44.2% | 27,052 | -54.4% | 0.01% | -50.0% |
| Q2 2017 | $197,000 | +68.4% | 59,360 | +366.1% | 0.01% | +100.0% |
| Q1 2017 | $117,000 | -85.9% | 12,736 | -84.5% | 0.01% | -86.5% |
| Q1 2016 | $832,000 | – | 82,313 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,042,989 | $8,571,000 | 0.75% |
| NEXTHERA CAPITAL LP | 634,715 | $1,346,000 | 0.26% |
| Endurant Capital Management LP | 219,114 | $465,000 | 0.21% |
| Birchview Capital, LP | 118,689 | $252,000 | 0.16% |
| Perceptive Advisors | 2,620,897 | $5,556,000 | 0.15% |
| Alambic Investment Management, L.P. | 53,972 | $114,000 | 0.09% |
| Sofinnova Investments, Inc. | 395,744 | $839,000 | 0.08% |
| Kazazian Asset Management, LLC | 31,475 | $67,000 | 0.06% |
| Broadfin Capital, LLC | 200,000 | $424,000 | 0.06% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 96,639 | $205,000 | 0.02% |